More than 800 individuals get booster shots in Muntinlupa

Published November 24, 2021, 2:07 PM

by Jonathan Hicap

The Muntinlupa City government has administered more than 800 booster shots mostly to fully vaccinated frontline health workers.

According to the City Health Office, as of Nov. 23, 869 doses of booster shots have been given. Of the total, 801, or 92 percent, are healthcare workers belonging to the A1 priority group.

Administration of booster shot in Muntinlupa (Muntinlupa PIO)

There were also five senior citizens (A2) and eight persons with comorbidities (A3) who received booster shots and additional doses in Muntinlupa.

The Muntinlupa City government rolled out the administration of booster shots to fully vaccinated healthcare workers on Nov. 19.

Booster vaccine, according to a report by the Health Technology Assessment Council (HTAC) of the Department of Health (DOH), is “a dose needed to address waning immunity over time in healthy individuals with sufficient immune response after the primary series.”

“Additional dose vaccination,” on the other hand, refers to “immunocompromised individuals whose immune response may be insufficient.”

Based on DOH guidelines, those who were fully vaccinated with Sinovac’s CoronaVac, AstraZeneca, Pfizer-BioNTech, Moderna and Sputnik V can get booster shots after at least six months from the date they got their second dose while those who got the single-dose Janssen vaccine, the booster shot is given at least three months after getting inoculated.

The DOH rolled out the administration of booster shots and additional doses to fully vaccinated senior citizens and immunocompromised persons with comorbidities on Nov. 22.

It said only those immunocompromised A3 will be given the additional dose. These are those with immunodeficiency state, people living with HIV (human immunodeficiency virus), active cancer or malignancy, transplant patients and patients under immunosuppressive treatments.

Immunocompromised is someone who has a “weakened immune system,” according to the US National Cancer Institute.